CONVERTIBLE PROMISSORY NOTE AXCELLA HEALTH INC.Loan and Security Agreement • September 23rd, 2022 • Axcella Health Inc. • Biological products, (no disgnostic substances) • New York
This Note: (a) is one of a series of similar Notes issued pursuant to that certain Securities Purchase Agreement (the “Purchase Agreement”), dated as of September 20, 2022, by and among the Company and the purchasers from time to time party thereto and (b) is subject in all respects to the terms and conditions set forth in the Purchase Agreement. This Note is convertible as provided in Section 4 of the Purchase Agreement. This Note is an unsecured obligation of the Company.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2022 • Axcella Health Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (the “Agreement”) is entered into as of September 20, 2022 (the “Effective Date”) by and among Axcella Health Inc., a Delaware corporation (the “Company”), and the purchasers who execute a counterparty signature page hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
